Cargando…

Low COAT platelets are frequent in patients with bleeding disorders of unknown cause (BDUC) and can be enhanced by DDAVP

Detalles Bibliográficos
Autores principales:	Segot, Amandine, Adler, Marcel, Aliotta, Alessandro, Matthey‐Guirao, Elena, Nagler, Michael, Bertaggia Calderara, Debora, Grandoni, Francesco, Gomez, Francisco J., Alberio, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314658/ https://www.ncbi.nlm.nih.gov/pubmed/35243754 http://dx.doi.org/10.1111/jth.15687

Ejemplares similares

Mechanisms Underlying Dichotomous Procoagulant COAT Platelet Generation—A Conceptual Review Summarizing Current Knowledge
por: Veuthey, Lucas, et al.
Publicado: (2022)

Thrombocytopathies: Not Just Aggregation Defects—The Clinical Relevance of Procoagulant Platelets
por: Aliotta, Alessandro, et al.
Publicado: (2021)

Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia
por: Aliotta, Alessandro, et al.
Publicado: (2020)

Thrombin generation in a woman with heterozygous factor V Leiden and combined oral contraceptives: A case report
por: Zermatten, Maxime G., et al.
Publicado: (2020)

Heparin-Induced Thrombocytopenia: A Review of New Concepts in Pathogenesis, Diagnosis, and Management
por: Marchetti, Matteo, et al.
Publicado: (2021)

Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis
por: Zermatten, Maxime G., et al.
Publicado: (2020)

Diagnostic utility of the ISTH bleeding assessment tool in patients with suspected platelet function disorders
por: Adler, Marcel, et al.
Publicado: (2019)

Identification of High Platelet Reactivity Despite ADP P2Y (12) Inhibitor Treatment: Two Populations in the Vasodilator-Stimulated Phosphoprotein Assay and Variable PFA-P2Y Shapes of Curve
por: Mariethoz, Cyril, et al.
Publicado: (2023)

Combinations of rapid immunoassays for a speedy diagnosis of heparin‐induced thrombocytopenia
por: Rittener‐Ruff, Luana, et al.
Publicado: (2022)

Another piece of knowledge in the puzzle of procoagulant COAT platelets
por: Aliotta, Alessandro, et al.
Publicado: (2022)

Utility of the Platelet Function Analyzer in Patients with Suspected Platelet Function Disorders: Diagnostic Accuracy Study
por: Kaufmann, Jonas, et al.
Publicado: (2020)

Treatment with ddAVP improves platelet-based coagulation in a rat model of traumatic hemorrhagic shock
por: Wirtz, Mathijs R, et al.
Publicado: (2022)

DDAVP Might Reduce the Risk of Preeclampsia in Pregnant Women with VWF Deficiency
por: Jahromi, Alireza Hamidian, et al.
Publicado: (2013)

Coronary Spastic Angina Induced after Oral Desmopressin (DDAVP) Administration
por: Adachi, Yusuke, et al.
Publicado: (2016)

SUN-410 Central Diabetes Insipidus Refractory to Oral Desmopressin (DDAVP)
por: Burdea, Liliana, et al.
Publicado: (2019)

Direct Oral Anticoagulant Drugs: On the Treatment of Cancer-Related Venous Thromboembolism and their Potential Anti-Neoplastic Effect
por: Grandoni, Francesco, et al.
Publicado: (2019)

Administration of DDAVP did not improve the pharmacokinetics of FVIII concentrate in a clinically significant manner
por: Loomans, Janneke I, et al.
Publicado: (2018)

MON-435 The Responsiveness To Ddavp Test Predicts Usp8 Mutation In Patients With Cushing's Disease
por: Shichi, Hiroki, et al.
Publicado: (2019)

cAMP-Epac1 signaling is activated in DDAVP-induced endolymphatic hydrops of guinea pigs
por: Chuan, Wang, et al.
Publicado: (2023)

Vasopressin Bolus Protocol Compared to Desmopressin (DDAVP) for Managing Acute, Postoperative Central Diabetes Insipidus and Hypovolemic Shock
por: Shukla, Anukrati, et al.
Publicado: (2017)

Fibrinolysis and bleeding of unknown cause
por: Mehic, Dino, et al.
Publicado: (2021)

Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider
por: Solari, Daria, et al.
Publicado: (2021)

Home blood sodium monitoring, sliding-scale fluid prescription and subcutaneous DDAVP for infantile diabetes insipidus with impaired thirst mechanism
por: Hameed, Shihab, et al.
Publicado: (2012)

Pitfalls in Interventional Pain Medicine: Hyponatremia after DDAVP for a Patient with Von Willebrand Disease Undergoing an Epidural Steroid Injection
por: Khan, Talal W., et al.
Publicado: (2017)

Pro‐haemostatic effect of DDAVP is partially derived through non‐classical (CD14(dim) /CD16 (++)) monocytes residing the spleen
por: Salarilak, Laleh, et al.
Publicado: (2022)

The Role of Plasma Transfusion in Massive Bleeding: Protecting the Endothelial Glycocalyx?
por: Barelli, Stefano, et al.
Publicado: (2018)

dDAVP Downregulates the AQP3-Mediated Glycerol Transport via V1aR in Human Colon HCT8 Cells
por: Centrone, Mariangela, et al.
Publicado: (2022)

Gastrointestinal Bleeding of Unknown Origin in Patients with Splenic Aneurysm
por: Kim, Jaihwan
Publicado: (2021)

Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial
por: Stalder, Grégoire, et al.
Publicado: (2022)

Managing argatroban in heparin‐induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin‐induced thrombocytopenia
por: Marchetti, Matteo, et al.
Publicado: (2022)

Preclinical Efficacy of [V(4)Q(5)]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer
por: Garona, Juan, et al.
Publicado: (2019)

Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield
por: Valke, Lars L. F. G., et al.
Publicado: (2022)

Vasopressin Analog [V(4)Q(5)]dDAVP Exerts Cooperative Anticancer Effects in Combination With Low-Dose 5-Fluorouracil on Aggressive Colorectal Cancer Models
por: Sobol, Natasha T., et al.
Publicado: (2023)

Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause
por: Gebhart, Johanna, et al.
Publicado: (2016)

The novel desmopressin analogue [V(4)Q(5)]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models
por: GARONA, JUAN, et al.
Publicado: (2015)

Health-related quality of life is impaired in bleeding disorders of unknown cause: results from the Vienna Bleeding Biobank
por: Mehic, Dino, et al.
Publicado: (2023)

A case of EDTA-dependent pseudothrombocytopenia: simple recognition of an underdiagnosed and misleading phenomenon
por: Nagler, Michael, et al.
Publicado: (2014)

Bleeding risks for uncharacterized platelet function disorders
por: Brunet, Justin, et al.
Publicado: (2020)

Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors
por: Engelhardt, Sophie, et al.
Publicado: (2022)

Known unknowns and unknown unknowns
por: Burki, Talha
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uh7qd92q8bj5p3eelsn8b7ofu4